Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
Introduction Methamphetamine use disorder is a global public health concern with no approved pharmacotherapies for its treatment. One recent randomised controlled trial conducted in the USA examined a combination of bupropion and naltrexone not readily available globally. Here, we report a trial pro...
Saved in:
Main Authors: | Jonathan Brett, Paul S Haber, Nicholas Lintzeris, Didier Jutras-Aswad, Nadine Ezard, Brendan Clifford, Krista J Siefried, Adrian John Dunlop, Liam Acheson, Carl Moller, Michael Christmass, Kirsten Morley, Steven Shoptaw, Madhukar H Trivedi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e092032.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)
by: Jonathan Brett, et al.
Published: (2025-02-01) -
A randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder: presentation of the study protocol
by: Jussi Jokinen, et al.
Published: (2022-06-01) -
Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials
by: Ashish R. Patel, et al.
Published: (2023-05-01) -
Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
by: Jegan Sakthivel Nadar, et al.
Published: (2018-01-01) -
Hemodynamic Effects of Methamphetamine and General Anesthesia
by: Keyvan M. Safdari, et al.
Published: (2022-01-01)